{"entity":{"type":"insider","cik":"0001362822","url":"/insider/0001362822","json_url":"/insider/0001362822.json","name":"Onaitis Matthew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":6,"first":"2010-01-05","last":"2012-01-04","span_basis":"filed_date"},"name_variants":[{"name":"Onaitis Matthew","source":"filing","n_filings":6,"first_seen":"2010-01-05","last_seen":"2012-01-04"}],"transactions":[{"id":3551961,"accession":"0001209191-12-000914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-000914","line_url":"/filing/0001209191-12-000914#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001362822","owner_name":"Onaitis Matthew","owner_display_name":"Onaitis Matthew","owner_url":"/insider/0001362822","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":0.4767,"price_display":"0.48","price_state":"stated","total_value":4290.3,"total_display":"4,290.30","total_whole":"4,290","shares_owned_after":155037.0,"shares_owned_after_display":"155,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-04","scope":"insider"},{"id":7488960,"accession":"0001209191-10-058427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-058427","line_url":"/filing/0001209191-10-058427#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001362822","owner_name":"Onaitis Matthew","owner_display_name":"Onaitis Matthew","owner_url":"/insider/0001362822","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8468.0,"shares_display":"8,468","price_per_share":2.6835,"price_display":"2.68","price_state":"stated","total_value":22723.878,"total_display":"22,723.88","total_whole":"22,724","shares_owned_after":64037.0,"shares_owned_after_display":"64,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider"},{"id":7389866,"accession":"0001209191-10-018096","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-10-018096","line_url":"/filing/0001209191-10-018096","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001362822","owner_name":"Onaitis Matthew","owner_display_name":"Onaitis Matthew","owner_url":"/insider/0001362822","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32081.0,"shares_display":"32,081","price_per_share":7.710373741466912,"price_display":"7.71","price_state":"stated","total_value":247356.5,"total_display":"247,356.50","total_whole":"247,357","shares_owned_after":44459.0,"shares_owned_after_display":"44,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-18","filed_date":"2010-03-22","scope":"insider","n_lines":3},{"id":7607561,"accession":"0001209191-10-014258","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-014258","line_url":"/filing/0001209191-10-014258#line-3","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001362822","owner_name":"Onaitis Matthew","owner_display_name":"Onaitis Matthew","owner_url":"/insider/0001362822","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":4.0155,"price_display":"4.02","price_state":"stated","total_value":120465.0,"total_display":"120,465.00","total_whole":"120,465","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-01","filed_date":"2010-03-03","scope":"insider"},{"id":7269788,"accession":"0001209191-10-007985","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-10-007985","line_url":"/filing/0001209191-10-007985#line-5","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001362822","owner_name":"Onaitis Matthew","owner_display_name":"Onaitis Matthew","owner_url":"/insider/0001362822","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":3.0251,"price_display":"3.03","price_state":"stated","total_value":181506.0,"total_display":"181,506.00","total_whole":"181,506","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-05","filed_date":"2010-02-09","scope":"insider"},{"id":7266730,"accession":"0001209191-10-001384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-001384","line_url":"/filing/0001209191-10-001384#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001362822","owner_name":"Onaitis Matthew","owner_display_name":"Onaitis Matthew","owner_url":"/insider/0001362822","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.07,"price_display":"1.07","price_state":"stated","total_value":5350.0,"total_display":"5,350.00","total_whole":"5,350","shares_owned_after":50712.0,"shares_owned_after_display":"50,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-31","filed_date":"2010-01-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Officer (SVP, General Counsel)","n_filings":6,"first_seen":"2010-01-05","last_seen":"2012-01-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001362822","retrieved_at":"2026-08-27T12:26:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}